Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study

The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?

(2022) Charlotte Ernstsen et al.   BRAIN

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study

(2022) Lanfranco Pellesi et al.   Frontiers in Neurology

Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis

(2021) Konstantina Drellia et al.   CEPHALALGIA

The complex relationship between estrogen and migraines: a scoping review

(2021) Nihaal Reddy et al.   Systematic Reviews

Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients

(2021) Hashmat Ghanizada et al.   ANNALS OF NEUROLOGY

Predictors of response to erenumab after 12 months of treatment

(2021) Carlo Baraldi et al.   Brain and Behavior

Correction to: Therapeutic novelties in migraine: new drugs, new hope?

(2019) Thien Phu Do et al.   JOURNAL OF HEADACHE AND PAIN

Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier

(2019) Rodrigo Noseda et al.   CEPHALALGIA

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research

(2018) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects

(2017) Thuy Vu et al.   PHARMACEUTICAL RESEARCH

Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms

(2016) Paula Carturan et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Changes in migraine before and after menopause in Japanese climacteric women

(2016) Kazuya Makita et al.   CEPHALALGIA

Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study

(2016) Vincent T. Martin et al.   HEADACHE

Deficiency of female sex hormones augments PGE2 and CGRP levels within midbrain periaqueductal gray

(2014) Dan Wang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Reduced trigeminovascular cyclicity in patients with menstrually related migraine

(2014) K. Ibrahimi et al.   NEUROLOGY

FDA Approval of Paroxetine for Menopausal Hot Flushes

(2014) Ronald J. Orleans et al.   NEW ENGLAND JOURNAL OF MEDICINE

Headaches in Middle-Aged Women during Menopausal Transition: A Headache Clinic-Based Study

(2012) Kyungmi Oh et al.   EUROPEAN NEUROLOGY

Mechanisms of Pain Modulation by Sex Hormones in Migraine

(2011) Saurabh Gupta et al.   HEADACHE

Efficacy of Escitalopram for Hot Flashes in Healthy Menopausal Women

(2011) Ellen W. Freeman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Migraine prevalence by age and sex in the United States: A life-span study

(2010) TW Victor et al.   CEPHALALGIA

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine

(2010) Min Yang et al.   CEPHALALGIA

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy

(2009) A. Benshushan et al.   CLIMACTERIC